Perigon Wealth Management’s Entergy ETR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
4,651
+529
+13% +$59.6K 0.01% 862
2026
Q1
$463K Buy
4,122
+10
+0.2% +$1.01K 0.01% 835
2025
Q4
$380K Buy
4,112
+91
+2% +$8.63K 0.01% 920
2025
Q3
$375K Buy
4,021
+182
+5% +$16K 0.01% 863
2025
Q2
$319K Sell
3,839
-752
-16% -$62.1K 0.01% 823
2025
Q1
$392K Buy
4,591
+16
+0.3% +$1.32K 0.01% 707
2024
Q4
$372K Buy
4,575
+131
+3% +$9.46K 0.01% 738
2024
Q3
$292K Buy
4,444
+270
+6% +$15.9K 0.01% 805
2024
Q2
$223K Buy
+4,174
New +$225K 0.01% 781
2021
Q1
Sell
-1,044
Closed -$52K 659
2020
Q4
$52K Buy
+1,044
New +$54.9K 0.01% 737
2018
Q2
Sell
-400
Closed -$16K 354
2018
Q1
$16K Hold
400
0.01% 466
2017
Q4
$16K Buy
400
+200
+100% +$8.38K 0.01% 436
2017
Q3
$8K Hold
200
﹤0.01% 526
2017
Q2
$8K Hold
200
﹤0.01% 506
2017
Q1
$8K Hold
200
﹤0.01% 541
2016
Q4
$8K Hold
200
﹤0.01% 588
2016
Q3
$8K Hold
200
﹤0.01% 506
2016
Q2
$8K Hold
200
﹤0.01% 381
2016
Q1
$8K Buy
+200
New +$7.26K ﹤0.01% 243

Other funds holding ETR

Perigon Wealth Management's ETR Position: Q2 2026 in Review

Perigon Wealth Management increased its Entergy (ETR) stake by 13% in Q2 2026, buying an estimated $59.6K and bringing the position to 4,651 shares worth $534K. The position accounts for 0.01% of the portfolio, ranked #862.

Perigon Wealth Management first reported a position in ETR in Q1 2016 and has held it in 19 quarters since. 1,335 funds tracked by Wall St. Rank hold ETR as of Q2 2026.

  • Perigon Wealth Management held 4,651 shares of Entergy worth $534K as of Q2 2026.
  • Perigon Wealth Management bought 529 Entergy shares in Q2 2026, an estimated $59.6K.
  • Entergy made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #862 holding.
  • Perigon Wealth Management first reported a position in Entergy in Q1 2016 and has held it in 19 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Entergy as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.